AiCare’s innovation in active intelligence and clinical data platform personalizes individual physical activity and biometric data to empower a healthy lifestyle
Our Team
![johnfeeBG johnfeeBG](https://aicare.co/wp-content/uploads/2024/06/johnfeeBG.png)
John Fee
CEO
John Fee holds a M.Eng from the University of Tennessee and was a founding member of Avanex. After the IPO of Avanex in 2000, John returned to MCI where he reported to the CTO and president and board of directors.
![CatherineBG CatherineBG](https://aicare.co/wp-content/uploads/2024/06/CatherineBG.png)
Catherine Fang, Ph.D.
Artificial Intelligence
Catherine Fang is a Distinguished Service Professor at Carnegie Mellon University. Previously, she has served as global/senior product manager and architect at LinkedIn, Yahoo, Bluekai (acquired by Oracle), and Sun Microsystems.
![PhillipYangBG PhillipYangBG](https://aicare.co/wp-content/uploads/2024/06/PhillipYangBG.png)
Phillip Yang, M.D.
Medical Innovation
Phillip Yang is a Professor of Medicine (Cardiovascular Medicine) at the Stanford University School of Medicine. He holds degrees from Stanford University and Yale University School of Medicine, and completed post-graduate training at UCLA and Stanford University Medical Centers.
![gerriBG gerriBG](https://aicare.co/wp-content/uploads/2024/06/gerriBG.png)
Gerri O’Riordan
Clinical Operations
Our Publications
Cloud-Based Machine Learning Platform to Predict Clinical Outcomes at Home for Patients With Cardiovascular Conditions Discharged From Hospital: Clinical Trial
(March 1, 2024)
Precise Measurement of Physical Activities and High-Impact Motion: Feasibility of Smart Activity Sensor System
(August 10, 2020)